Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  sodium phenylbutyrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-13 of 13 for your search:
Start Over
Phase II Pilot Study of Phenylbutyrate Plus Azacytidine in Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99060, NCI-T99-0091, NCT00006019, T99-0091
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NHLBI
Protocol IDs: CDR0000068165, NHLBI-00-H-0156, NCI-171, 171, NCT00006240
Phase I Study of Twice-Daily Intravenous Phenylbutyrate for Advanced Cancer (Summary Last Modified 06/98)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-94111, NCI-T94-0170D, T94-0170
Phase I Study of Phenylbutyrate as a 120-Hour Infusion in Refractory Solid Tumors (Summary Last Modified 05/1999)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: JHOC-9502, NCI-T94-0097D, T94-0097
Phase I Study of Phenylbutyrate for Myelodysplastic Syndrome and Relapsed Acute Myeloid Leukemia (Summary Last Modified 10/1999)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: JHOC-9446, NCI-T94-0196D, T94-0196
Phase I Study of Phenylbutyrate in Children with Refractory Malignancies (Summary Last Modified 07/1999)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 2 to 21
Sponsor: NCI
Protocol IDs: TCCC-T96-0044, NCI-T96-0044O, T96-0044
Phase I and Pharmacokinetic Study of Phenylbutyrate in Pediatric Patients With Refractory Cancer (Summary Last Modified 01/2001)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 2-21
Sponsor: NCI
Protocol IDs: NCI-97-C-0051G, BCM-H5292, NCI-T96-0044
Phase I Study of Phenylbutyrate Plus Tretinoin in Patients With Acute Promyelocytic Leukemia, Neuroblastoma, Non-Small Cell Lung Cancer, or Prostate Cancer (Summary Last Modified 04/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: MSKCC-98081, NCI-T98-0043, T98-0043
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067531, J9950, U01CA070095, R01CA067803, P30CA006973, JHOC-99072307, NCI-T99-0092, JHOC-J9950, T99-0092, NCT00004871
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067799, JHOC-99120302, JHOC-J9982, NCI-270, 270, NCT00005639
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068164, J9879, R01CA067803, P30CA006973, JHOC-J9879, JHOC-99072306, NCI-T98-0068, T98-0068, NCT00006239
Phase I Study of Phenylbutyrate by Continuous Infusion in Patients with Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-93-C-0090L, NCI-CPB-307
Start Over